203 related articles for article (PubMed ID: 23575469)
1. Evolution of the techniques of radiation therapy in the management of lymphoma.
Hoppe RT
Int J Clin Oncol; 2013 Jun; 18(3):359-63. PubMed ID: 23575469
[TBL] [Abstract][Full Text] [Related]
2. [Radiotherapy of lymphomas].
Barillot I; Mahé MA; Antoni D; Hennequin C
Cancer Radiother; 2016 Sep; 20 Suppl():S244-8. PubMed ID: 27521031
[TBL] [Abstract][Full Text] [Related]
3. Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
Specht L
Curr Treat Options Oncol; 2016 Jan; 17(1):4. PubMed ID: 26739151
[TBL] [Abstract][Full Text] [Related]
4. Modern radiotherapeutic strategies in the management of lymphoma.
Ballas L
Future Oncol; 2015; 11(6):1011-20. PubMed ID: 25760980
[TBL] [Abstract][Full Text] [Related]
5. Importance of PET/CT scan use in planning radiation therapy for lymphoma.
Milana MA; Marko E; Miroslav L; Tihomir D
Asian Pac J Cancer Prev; 2015; 16(5):2051-4. PubMed ID: 25773849
[TBL] [Abstract][Full Text] [Related]
6. Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy.
Horn S; Fournier-Bidoz N; Pernin V; Peurien D; Vaillant M; Dendale R; Fourquet A; Kirova YM
Cancer Radiother; 2016 Apr; 20(2):98-103. PubMed ID: 26992750
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy of lymphomas.
Balosso J; Missohou F; Antoni D; Hennequin C; Mahé MA; Simon L; Demoor-Goldschmidt C
Cancer Radiother; 2022; 26(1-2):388-396. PubMed ID: 34953716
[TBL] [Abstract][Full Text] [Related]
8. Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT).
Yahalom J
Eur J Haematol Suppl; 2005 Jul; (66):90-7. PubMed ID: 16007875
[TBL] [Abstract][Full Text] [Related]
9. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
[TBL] [Abstract][Full Text] [Related]
10. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).
Specht L; Yahalom J; Illidge T; Berthelsen AK; Constine LS; Eich HT; Girinsky T; Hoppe RT; Mauch P; Mikhaeel NG; Ng A;
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):854-62. PubMed ID: 23790512
[TBL] [Abstract][Full Text] [Related]
11. INFRADIAPHRAGMAL RADIOTHERAPY IN PATIENTS WITH LYMPHOMA: VOLUME DEFINITION AND SIDE EFFECTS.
Galunić-Bilić L; Šantek F
Acta Clin Croat; 2018 Sep; 57(3):554-560. PubMed ID: 31168189
[TBL] [Abstract][Full Text] [Related]
12. [Radiation therapy for malignant lymphoma].
Asakawa I; Tamamoto T; Hasegawa M
Nihon Rinsho; 2014 Mar; 72(3):468-72. PubMed ID: 24724405
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
14. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.
Pinnix CC; Smith GL; Milgrom S; Osborne EM; Reddy JP; Akhtari M; Reed V; Arzu I; Allen PK; Wogan CF; Fanale MA; Oki Y; Turturro F; Romaguera J; Fayad L; Fowler N; Westin J; Nastoupil L; Hagemeister FB; Rodriguez MA; Ahmed S; Nieto Y; Dabaja B
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):175-82. PubMed ID: 25863764
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.
Song DY; Jones RJ; Welsh JS; Haulk TL; Korman LT; Noga S; Goodman S; Herman M; Mann R; Marcellus D; Vogelsang G; Ambinder RF; Abrams RA
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):166-71. PubMed ID: 12909229
[TBL] [Abstract][Full Text] [Related]
16. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
[TBL] [Abstract][Full Text] [Related]
17. Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison.
König L; Bougatf N; Hörner-Rieber J; Chaudhri N; Mielke T; Klüter S; Haefner MF; Rieken S; Haberer T; Debus J; Herfarth K
Strahlenther Onkol; 2019 Jul; 195(7):677-687. PubMed ID: 30972453
[TBL] [Abstract][Full Text] [Related]
18. Proton therapy in the management of lymphoma.
Ho CK; Flampouri S; Hoppe BS
Cancer J; 2014; 20(6):387-92. PubMed ID: 25415683
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiotherapy for lymphoma involving the mediastinum.
Goodman KA; Toner S; Hunt M; Wu EJ; Yahalom J
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):198-206. PubMed ID: 15850922
[TBL] [Abstract][Full Text] [Related]
20. Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy?
Knäusl B; Lütgendorf-Caucig C; Hopfgartner J; Dieckmann K; Kurch L; Pelz T; Pötter R; Georg D
Strahlenther Onkol; 2013 Jan; 189(1):54-61. PubMed ID: 23161118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
